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(S–K)Abstract The purpose of the present study was to rate the level of spread of asthma-induced bron-
chial morphological changes on chest X-ray (CXR), using the modiﬁed Shwachman–Kulczycki (S–
K) rating scale as predicted by the dynamic of blood cell count (CBC). A sample of 40 asthma
patients’ records was classiﬁed into 4 groups based on their clinical presentations and frequency
of their visits to the hospital; Group-1 62 visits per week with reversible symptoms, Group-2
P2 visits per week with irreversible symptoms, Group-3: P3–4 visits per week with irreversible
symptoms; Group-4: patients with severe shortness of breath in whom SaO2 was threatening, hence
were admitted as inpatients. Patients’ CXR were scored based on the modiﬁed Shwachman–Kulc-
zycki (S–K) scale rating. Blood analysis showed that RBC and their indices (HCT, HGB, MCH,
RDW) were highest in group-2. White blood cells and their derivatives (NEU, EOS and LYM) were
highest in group 4. CXR for group-2 showed bilateral increased bronchovascular markings but nor-
mal both lung ﬁelds and ruled out for costo-phrenic angles type of fever. Chest X-ray for group-3
showed hyperinﬂation, perihilar marking associated with bronchial thickening and unfolding aorta.
In patients in group-4 development of broncho-pneumonic inﬁltration type of SOB and some evi-
dence of bronchial edema with signiﬁcant (p< 0.05) elevation in WBC were observed. The regres-
sion of S–K score on the dynamic of some CBC parameters was signiﬁcant (p< 0.05). The best
subsets that describe the model were:
S–K ¼ 14:242þ b1NEUð1:28Þ þ b2EOSð10:929Þ þ b3HCTð0:577Þ þ b4HGBð:898Þ þ b5RDWð0:546Þ
þ b6RBCð1:966Þ þ e
326 A.S.A. Haffor et al.Based on the results of the present study it can be concluded that monitoring CBC parameters
can be an objective estimate of the S–K score for CXR in order to classify the severity of asthma
using an objective numerical value to assess patients’ treatment follow up, without the need for X-
ray equipment setup.
 2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis.Introduction
Asthma is a lung disease that is characterized by inﬂammation,
obstruction, and hyper-responsiveness of the airways. Chronic
asthma represents a chronic inﬂammatory process of the air-
ways followed by healing whose end results involve altered
morphology of the airways referred to as remodeling [10]
which in turn leads to a widespread narrowing of different
degrees in severity.
The majority of guidelines classify asthma’s severity into
four levels of severities; intermittent, mild persistent, moderate
persistent and severe persistent (NAEPP, NAC) based on clin-
ical symptoms and pulmonary function tests [44]. There were
no previous studies that had utilized chest radiology report
(CXR) to classify asthma severity. CXR has been considered
the ‘gold standard’ with respect to the presence or absence of
relevant morphological pathological changes regarding the
progression of bronchial thickness inducted by asthma. Specif-
ically, a radiology report considered the ‘gold standard’ with
respect to the presence or absence of relevant pathological
changes with regard to asthma-induced bronchial morpholog-
ical progressions [43]. CXR clariﬁes the clinical signiﬁcance of
hyperinﬂation, bronchial wall thickening or small localized
areas of atelectasis and those clinical signs are considered pow-
erful morphological indicators to differentiate between mild,
moderate and severe asthma that are manifested by the early
inﬂammatory responses [30]. Additionally CXR is necessary
when there is no response to initial therapy, with worsening
inﬂammatory responses. Most often primary cares’ physicians
do not require a chest X-ray (CXR) mainly because of the tre-
mendous cost expenses and lack of X-ray equipment setups as
well as lack of specialist staff.
On the other hand the dynamic of blood cell count (CBC)
has been used as a reliable clinical predictor for the severity of
a variety of inﬂammatory conditions [35,4], yet its implementa-
tions to classify asthma severity have been ignored. Clearly,
chronic inﬂammatory process of the airways must be associ-
ated with a signiﬁcant rise in white cell count (WBC), yet its
implementations to classify the severity of asthma had been
poorly understood. There is a general agreement that asthma
involves progressive bronchial wall thickness mainly due to
inﬂammatory responses that involve proliferation and
migrations of white blood cell; eosinophil, neutrophil and lym-
phocyte [34,40]. Similarly the utilization of the dynamic
changes in red blood cells (RBC) counts and their indices
had been ignored in asthma classiﬁcation. It is reasonable to
assume that early stages of asthma elicit hypoxic stimulus that
inducts the release of RBC whereas late stages of asthma rep-
resent sustained hypoxia which leads to tissue damage and
ischemia which in turn impact the sources (organs) of RBC
productions [28,35,9]. Altogether there is a need to model
the relationships of the dynamic changes in blood cell countsand the morphological changes in CXR, as clinical outcome
for treatment and follow up of asthma in primary care clinic.
The reasons for modeling this relationship are that many
general physician ofﬁces and primary clinics may have an
automated CBC system which is tremendously less expensive,
easy to operate and able to generate self-explanatory
comprehensive CBC report [21,12,11,29,38,20], from which
the morphological changes in CXR can be easily predicted.
Shwachman–Kulczycki (S–K) rating score was ﬁrst imple-
mented as a quantitative score for the assessments of the
morphological changes in CXR of cystic ﬁbrosis [45,5,13].
The present study aimed to implement the use of the modiﬁed
S–K scoring system in asthma in relation to blood cell count
(CBC) dynamic as an objective score to classify asthma
severity, hence provides an optimization of the control of
asthma episodes and treatment follow up. Furthermore the
quantitative rating scale of the radiological appearances on
CXR in asthma can provide a numerical value to quantify
the impact of underlying chronic inﬂammations of the
bronchial tree, hence provides useful diagnostic proﬁle. Fur-
thermore a numerical prediction of CXR rating score based
on CBC dynamic allows for its implementations in primary
care clinic and in general physician ofﬁces without the need
for X-ray equipment setup.
The present study is the ﬁrst report to implement
S–K – CBC-dependent rating score system in asthma. Our goal
was to introduce a reliable, simple and objective score to clas-
sify the progression of asthma as well as monitor treatment
effectiveness. We have derived a simple regression equation
from CBC dynamic to provide single numerical score to clas-
sify the morphological pathological changes on CXR of
asthma.Materials and methods
Sample selection
A sample of 40 adult asthmatic patients, ranging in age from
20 to 55 years old was classiﬁed into four groups of different
severities; mild, moderate, heavy and severe. Asthma patients
with additional clinical conditions related to cancer, eczema,
and chronic illnesses (diabetes mellitus, chronic kidney disease,
etc.), or chronic inﬂammation (rheumatoid arthritis, cigarette
smokers) were excluded from the study.
Patients’ classification criteria
The assessments of asthma severity were based on a combina-
tion of the clinical presentation of the patients and airﬂow lim-
itation parameters that included number of patient visits
(episodes) per week, respiratory rate (FR), peak expiratory
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with O2 (SaO2). The variability in these parameters allowed
for subdivided asthma severity into four categories: mild inter-
mittent, mild persistent, moderate persistent, and severe persis-
tent [36,37].
Mild intermittent (G-1)
The respiratory rate (FR) was 18–22, without the use of acces-
sory muscles of respiration breathing, peak expiratory ﬂow
(PEF) was above 80% of predicted and heart rate was elevated
but below 100 beats per minute without the presence of pulsus
paradoxus. Saturation of arterial blood with O2 (SaO2) was at
95% or above.
Mild persistent (G-2)
The respiratory rate (FR) was elevated to 23–29 with the use of
accessory muscles of respiration associated with suprasternal
retractions and peak expiratory ﬂow (PEF) was below 80%
but above 60% of predicted. The heart rate ranged between
100 and 120 beats per minute and pulsus paradoxus was pre-
sented (10–20 mmHg). Auscultation of the chest revealed loud
expiratory wheezing. SaO2 was reduced to 91–95%on room air.
Moderate persistent (G-3)
The respiratory rate (FR) was greater than 30 breaths per min-
ute, with the use of accessory muscles of respiration which
caused maximal retractions and peak expiratory ﬂow (PEF)
was below 60% but above 40% of predicted. The heart rate
was more than 120 beats per minute. Loud biphasic (expiratory
and inspiratory) wheezing was heard. Pulsus paradoxus is often
present (20–40 mmHg). SaO2was less than 91%but above 85%.
Severe persistent (G-4)
The respiratory rate was greater than 30 breaths per minute,
with the use of accessory muscles of respiration which caused
maximal retractions and peak expiratory ﬂow (PEF) was
below 40% of predicted. The heart rate was more than 120
beats per minute. Loud biphasic (expiratory and inspiratory)
wheezing was heard. Pulsus paradoxus is often present (20–
40 mmHg). SaO2 was less than 85%.
Statistical analysis
Statistical analysis was conducted using SPSS for Windows, v.16
(SPSS Inc., Chicago, IL, USA). Data were tested for normality
using normal probability subroutine. One Way Analysis of vari-
ance was used to evaluate groups’ means differences. Tukey, post
hoc multiple comparisons, was used to conduct pair-wise means
comparisons. The effect of the independent variables on selected
outcome variables was evaluated using step-wise multiple regres-
sion analysis. The linearity and correlationmatrix among selected
outcome variables was generated using Pearson productmoment
correlation. Intra-class multiple correlations were used to evalu-
ate reliability of the rating score of the X-ray image based on
the evaluators’ pathological observations [49].
X-ray imaging (CXR)
Standard chest radiography in the posteroanterior (PA) was
obtained during full inspiration with patient erect, feet apart,chin rested on ﬁlm top edge, hands on lower hips, elbows
partially ﬂexed, the shoulders rotated forward (to move the
clavicles below apices), top of ﬁlm 5 cm above the shoulders
(to include the apices). Once the patient was asked to take deep
inspiration and hold it, exposure was carried out on the 2nd
arrested inspiration [30].
Modified Shwachman–Kulczycki (S–K) rating scale
The Shwachman–Kulczycki (S–K) scale was originally
conducted on cystic ﬁbrosis patients with 25 numerical value
for healthy and 5 most severe [45,29]. We modiﬁed the S–K
scale by excluding the ﬁrst category for healthy, hence the
modiﬁed score used in the present study ranges from 5 to 20
with 5 being most severe and 20 being lowest severe asthma.
We also allowed a range of 3 in each category to allow for
more accuracy by the evaluators. For example a range of 3
to 5 (rather than single point of 5) wherein 3 is observed severe
signs at best, 4 observed severe signs, and 5 observed severe
signs at least. Similarly 8–10 range implied 3 observations of
moderate signs, 13–15 implied a range of mild signs and
18–20 implied a range of intermittent signs of asthma.
Image rating criteria
A modiﬁed S–K rating score (range 5–20) was used to eval-
uate the condition of asthma, based on rough estimate of
the observed bronchial pathological appearance on the
CXR image. The average score of 3chest specialists was used
as point of estimate to the bronchial asthma severity. The
evaluators focused on the presence of various levels of esti-
mated bronchial asthma as evident by the varying observed
appearance of peribronchial thickening with tram-track pat-
tern, bronchial thickness, pulmonary nodules, air trapping,
perhaps atelectasis with mucus blocking associated with
hyperinﬂation. Every effort was made to exclude co-morbid-
ities such as bronchogenic carcinoma, left ventricular failure,
viral bronchiolitis, foreign body aspiration and
bronchiectasis.Results
Descriptive results
Descriptive findings of the modified Shwachman–Kulczycki
rating scale
The average S–K rating score of the assessment of patients’
chest X-ray (CXR) of asthma severity of the three evaluators
for all groups is presented in Table 1.
Descriptive findings of red blood cells and their indices
The statistical descriptive measures from SPSS program out-
put, for all asthmatic patient groups (mild, moderate, heavy
and severe asthma), with regard to red blood cells (RBC)
and their indices are presented in Table 2. The RBC indices
included; hemoglobin (HGB), hematocrit (HCT), mean
corpuscular volume (MCV), mean corpuscular hemoglobin
(MCH, mean corpuscular hemoglobin concentration
(MCHC) and random distribution of width (RDW)
[41,12,50,42].
Table 1 Descriptive statistics of the modiﬁed Shwachman–
Kulczycki rating score.
Evaluator Group
membership
Mean Std.
deviation
N
First evaluator Group1 18.8000 2.29976 10
Group2 14.4000 1.57762 10
Group3 9.2000 2.82056 10
Group4 5.0000 1.24722 10
Second evaluator Group1 18.6000 1.77639 10
Group2 14.6000 .96609 10
Group3 9.3000 2.66875 10
Group4 4.9000 1.66333 10
Third evaluator Group1 19.0000 1.69967 10
Group2 14.5000 1.26930 10
Group3 9.2000 3.04777 10
Group4 5.6000 1.50555 10
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derivatives
The statistical descriptive measures from the SPSS program
output, for all asthmatic patient groups (mild, moderate, heavy
and severe asthma) for white blood cells (WBC) and their
derivatives are presented in Table 3. The differentiated forms
for WBC included basophils (BASO), eosinophils (EOS),Table 2 Descriptive results blood cells and associated indices.
Measures Asthma classiﬁcation* N Mean Std. de
RBC Intermittent 10 4.830 .34976
Persistent mild 10 5.990 .48655
Persistent moderate 10 4.100 .45947
Persistent severe 10 4.250 .65021
HGB Intermittent 10 11.500 .52705
Persistent mild 10 16.7700 1.05625
Persistent moderate 10 14.8100 .61545
Persistent severe 10 12.5000 .97183
HCT Intermittent 10 39.3000 .82327
Persistent mild 10 50.6700 4.26043
Persistent moderate 10 31.2000 2.25093
Persistent severe 10 33.0000 1.88562
MCV Intermittent 10 80.5000 8.11377
Persistent mild 10 84.6200 2.87897
Persistent moderate 10 75.1000 8.15748
Persistent severe 10 78.9000 3.92853
MCH Intermittent 10 24.7000 3.49762
Persistent Mild 10 27.4100 1.51324
Persistent Moderate 10 20.3000 3.09300
Persistent Severe 10 29.3000 3.86005
MCHC Intermittent 10 31.1100 1.38359
Persistent Mild 10 32.5700 .86673
Persistent Moderate 10 26.8800 1.93034
Persistent Severe 10 30.2400 1.35499
RDW Intermittent 10 12.8000 .91894
Persistent Mild 10 11.6000 .78174
Persistent Moderate 10 14.6000 2.67499
Persistent Severe 10 10.3000 2.21359
* According to patients’ classiﬁcation criteria in the method section.monocytes (MON), neutrophils (NEU) and lymphocytes
(LYM).
The mean leukocyte count increased from 7.47  103 in
moderate asthma patients to 8.68  103 in heavy asthma
patients to 11.93  103 (day2) in severe asthma patients. The
mean neutrophil count increased from 3.23  103 in moderate
asthma to 5.15  103 in heavy asthma to 6.59  103 in severe
asthma. The mean lymphocyte count increased from
3.2  103 in moderate asthma to 4.02  103 in severe asthma.
The mean eosinophil count increased from 0.211  103 in
moderate asthma to 0.45  103 in severe asthma. The mean
basophil count increased from 0.05  103 in moderate asthma
to 0.12  103 in severe asthma.
Based on the results of the present study, it can be con-
cluded that asthma induced progressive changes in the total
WBC, neutrophil, lymphocyte and eosinophil count. The
increase was more profound in group 4, but was also seen in
group 3 to some extent. Perhaps these changes can be used
in evaluating complications of asthma, such as infections
[14,38]. In other words an increase in eosinophils, basophils,
neutrophils and lymphocytes reﬂects a bronchial infection
and/or parenchyma infection secondary to bronchial inﬂam-
mation that was caused by microorganisms during high stages
of chronic asthma.
It is very important to realize that the white blood cell dif-
ferential is often used to help diagnose diseases and conditionsviation Std. error 95% Conﬁdence interval for mean
Lower bound Upper bound
.11060 4.5798 5.0802
.15386 5.6419 6.3381
.14530 3.7713 4.4287
.20562 3.7849 4.7151
.1667 11.1230 11.8770
.33402 16.0144 17.5256
.19462 14.3697 15.2503
.30732 11.8048 13.1952
.26034 38.7111 39.8889
1.34726 47.6223 53.7177
.71181 29.5898 32.8102
.59628 31.6511 34.3489
2.56580 74.6958 86.3042
.91041 82.5605 86.6795
2.57962 69.2645 80.9355
1.24231 76.0897 81.7103
1.10604 22.1980 27.2020
.47853 26.3275 28.4925
.97809 18.0874 22.5126
1.22066 26.5387 32.0613
.43753 30.1202 32.0998
.27408 31.9500 33.1900
.61043 25.4991 28.2609
.42849 29.2707 31.2093
.29059 12.1426 13.4574
.24721 11.0408 12.1592
.84591 12.6864 16.5136
.70000 8.7165 11.8835
Table 3 Descriptive results differential white blood cells.
Measures Asthma condition N Mean Std. deviation Std. error 95% Conﬁdence interval for mean
Lower bound Upper bound
BASO Intermittent 10 .0530 .02214 .00700 .0372 .0688
Persistent mild 10 .2180 .31766 .10045 .0092 .4452
Persistent moderate 10 .1610 .03542 .01120 .1357 .1863
Persistent severe 10 .1200 .03859 .01220 .0924 .1476
EOS Intermittent 10 .2110 .03755 .01187 .1841 .2379
Persistent mild 10 .3830 .17056 .05394 .2610 .5050
Persistent moderate 10 .3170 .05618 .01777 .2768 .3572
Persistent severe 10 .4510 .10093 .03192 .3788 .5232
MONO Intermittent 10 .6050 .12826 .04056 .5133 .6967
Persistent mild 10 .4820 .12435 .03932 .3930 .5710
Persistent moderate 10 .5040 .13624 .04308 .4065 .6015
Persistent severe 10 .6170 .17739 .05610 .4901 .7439
LYM Intermittent 10 3.2000 .90554 .28636 2.5522 3.8478
Persistent mild 10 2.8840 .63813 .20179 2.4275 3.3405
Persistent moderate 10 3.0000 .24495 .07746 2.8248 3.1752
Persistent severe 10 4.0200 .97843 .30941 3.3201 4.7199
NEU Intermittent 10 3.2300 .34976 .11060 2.9798 3.4802
Persistent mild 10 3.0640 1.44938 .45834 2.0272 4.1008
Persistent moderate 10 5.1500 .43012 .13601 4.8423 5.4577
Persistent severe 10 6.5900 1.40274 .44358 5.5865 7.5935
WBC Intermittent 10 7.4700 .87693 .27731 6.8427 8.0973
Persistent mild 10 6.9760 1.64140 .51906 5.8018 8.1502
Persistent moderate 10 8.6800 .60700 .19195 8.2458 9.1142
Persistent severe 10 11.9300 1.50779 .47681 10.8514 13.0086
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include: neutrophils, lymphocytes, monocytes, eosinophils and
basophils. The differential totals the number of each type and
determines if the cells are present in normal proportion to one
another, if one cell type is increased or decreased, or if imma-
ture cells are present. This information is useful in helping to
diagnose the speciﬁc progression in causing an illness, such
as asthma, allergies, inﬂammations, and neoplasm. In addi-
tion, some diseases trigger a response by the immune system
that causes an increase in certain types of WBCs. A differential
may give clues to the speciﬁc cause of that immune e response.
Inferential findings
Stepwise multiple regression model
The multiple stepwise regression models of the independent
variables (NEU, EOS, HCT, HGB, RDW and RBC) and the
dependent variable (S–K score) are presented in Table 4.
Although data were collected, without order with respect to
time, the model did not exhibit signiﬁcant positive nor negative
autocorrelation since the Durbin–Watson statistic was above 2
and below 4 implying that there were no autocorrelations
among the predictor variables. As can be seen from Table 4
the mean regression square (R2) and the adjusted proportion
of regression sum of square (R2adjusted) were improved in each
step and had reached its maximum value of 0.810 and 0.776,
respectively, when all the 6 independent variables plus the
intercept term are included in the model.
As noted from table the model terminated after adding 6
independent explanatory variables with signiﬁcant (p< 0.05)impact on S–K score rating as appeared on the chest X-ray
image. The ﬁrst variable that entered into the model was neu-
trophil (NEU) with p value of 0.000. The second variable that
entered into the model was eosinophils (EOS) with p value of
0.003. The third variable that entered into the model was
hematocrit (HCT) with p value of 0.013. The fourth variable
that entered into the model was hemoglobin (HGB) with p
value of 0.008. The ﬁfth that variable entered into the model
was random distribution width of red blood cells with p value
of 0.032. The sixth variable that entered into the model was red
blood cell (RBC) with p value of 0.049, implying that all pre-
dicted variables entered in the model had signiﬁcantly
(p< 0.05) improved the prediction of S–K score rating model.
Model evaluation
Analysis of variance was used to test the signiﬁcance of the
regression mean square (Table 5). As noted from table, the F
statistics was greater than the critical F, hence the decision
was to reject the null hypothesis and conclude that the addition
of CBC predicted variables improved the prediction of S–K
score rating appeared as clinically diagnosed on the CXR
image.
The population slopes of the independent variables namely
NEU, EOS, HCT, HGB, RDW and RBC) were tested to
determine the signiﬁcance of the impact of their predictability
on the S–K score. As can be seen from Table 6, the results of
‘‘t” test for each of the independent variables included in the
MR model were signiﬁcant (p< 0.05). Clearly shown from
Table 6, there was no collinearity among those predictors
implying that each of the independent variables had
Table 4 Stepwise multiple regression model summaryg.
Model R R2 Adjusted R2 Std. E. of the estimate Change statistics Durbin–Watson
R2 change F change df1 df2 Sig. F change
1 .739a .546 .535 3.77565 .546 45.783 1 38 .000
2 .801b .642 .623 3.39959 .096 9.872 1 37 .003
3 .836c .699 .674 3.15984 .057 6.828 1 36 .013
4 .869d .755 .727 2.89144 .056 7.994 1 35 .008
5 .887e .786 .755 2.73957 .031 4.988 1 34 .032
6 .900f .810 .776 2.61951 .024 4.188 1 33 .049 2.032
a Predictors: (Constant), NEU.
b Predictors: (Constant), NEU, EOS.
c Predictors: (Constant), NEU, EOS, HCT.
d Predictors: (Constant), NEU, EOS, HCT, HGB.
e Predictors: (Constant), NEU, EOS, HCT, HGB, RDW.
f Predictors: (Constant), NEU, EOS, HCT, HGB, RDW, RBC.
g Dependent variable: Score.
Table 5 ANOVA for testing partial and total modelg.
Model Sum of squares df Mean square F Sig.
1 Regression 652.666 1 652.666 45.783 .000a
Residual 541.709 38 14.256
Total 1194.375 39
2 Regression 766.758 2 383.379 33.172 .000b
Residual 427.617 37 11.557
Total 1194.375 39
3 Regression 834.930 3 278.310 27.874 .000c
Residual 359.445 36 9.985
Total 1194.375 39
4 Regression 901.761 4 225.440 26.965 .000d
Residual 292.614 35 8.360
Total 1194.375 39
5 Regression 939.196 5 187.839 25.028 .000e
Residual 255.179 34 7.505
Total 1194.375 39
6 Regression 967.935 6 161.322 23.510 .000f
Residual 226.440 33 6.862
Total 1194.375 39
a Predictors: (Constant), NEU.
b Predictors: (Constant), NEU, EOS.
c Predictors: (Constant), NEU, EOS, HCT.
d Predictors: (Constant), NEU, EOS, HCT, HGB.
e Predictors: (Constant), NEU, EOS, HCT, HGB, RDW.
f Predictors: (Constant), NEU, EOS, HCT, HGB, RDW, RBC.
g Dependent variable: Score.
330 A.S.A. Haffor et al.contributed signiﬁcantly, regardless of their relative contribu-
tion in the overall model. In addition the variance inﬂation fac-
tor (VIF) was not signiﬁcant because all corresponding values
were below 5 with the exception of the VIP regarding HCT
which was equal to 5.469 implying the absence of variance
inﬂation effects, hence the regression model is meaningfully
applicable.
Stepwise regression model
As noted from Table 6 the model terminated after adding 6
independent explanatory variables with signiﬁcant (p< 0.05)impact on S–K score rating as appeared on the chest X-ray
image. The best subsets included constant of 14.242 and 6
parameters; neutrophil (NEU) with b value of 1.208, eosino-
phil (EOS) with b value of 10.929, hematocrit (HCT) with b
value of 0.577, hemoglobin with b value of 0.898, random
distribution width with b value of 0.546 and red blood cell
(RBC) with b value of 1.966. The best subsets that describe
the model are as follows:
S–K ¼ 14:242þ b1NEUð1:28Þ þ b2EOSð10:929Þ þ b3HCTð0:577Þ
þ b4HGBð:898Þ þ b5RDWð0:546Þ þ b6RBCð1:966Þ þ e
Table 6 Testing the signiﬁcance of coefﬁcients of partial and total model.
Model Unstandardized coeﬃcients Standardized coeﬃcients t Sig. Collinearity statistics
B Std. error Beta Tolerance VIF
1 (Constant) 22.467 1.641 13.692 .000
NEU 2.294 .339 .739 6.766 .000 1.000 1.000
2 (Constant) 25.579 1.779 14.381 .000
NEU 1.973 .322 .636 6.130 .000 .899 1.112
EOS 13.386 4.260 .326 3.142 .003 .899 1.112
3 (Constant) 15.375 4.241 3.626 .001
NEU 1.273 .402 .410 3.170 .003 .499 2.003
EOS 17.539 4.267 .427 4.110 .000 .775 1.291
HCT .220 .084 .322 2.613 .013 .550 1.817
4 (Constant) 20.488 4.281 4.786 .000
NEU 1.275 .367 .411 3.471 .001 .499 2.003
EOS 14.380 4.061 .350 3.541 .001 .716 1.397
HCT .328 .086 .481 3.819 .001 .440 2.271
HGB .746 .264 .299 2.827 .008 .624 1.602
5 (Constant) 12.325 5.460 2.257 .031
NEU 1.134 .354 .365 3.203 .003 .483 2.070
EOS 11.049 4.127 .269 2.677 .011 .622 1.607
HCT .397 .087 .583 4.561 .000 .385 2.600
HGB .908 .260 .364 3.488 .001 .576 1.737
RDW .485 .217 .209 2.233 .032 .718 1.394
6 (Constant) 14.242 5.304 2.685 .011
NEU 1.208 .340 .389 3.550 .001 .478 2.094
EOS 10.929 3.947 .266 2.769 .009 .622 1.607
HCT .577 .121 .846 4.771 .000 .183 5.469
HGB .898 .249 .360 3.606 .001 .575 1.738
RDW .546 .210 .235 2.605 .014 .703 1.423
RBC 1.966 .961 .317 2.047 .049 .240 4.175
Reliable quantitative score for grading chest X-ray 331Based on the results of the present study it can be concluded
that monitoring CBC parameters can be an objective estimate
of the S–K score in order to classify the severity of asthma
without the need for CXR equipment setup, hence provides
quantitative and objective measure for asthma patients’ treat-
ment progression and follow up.
Discussion
The ﬁrst ﬁndings of the present study were increased RBC and
their related indices (HBG, RDW, HCT, MCV,), in mild inter-
mittent asthma patients then decreased in severe asthma, as
compared with the average population’s mean values. A similar
increase in RBC had been reported in chronic obstructive dis-
eases (COPD) such as emphysema and in respiratory insufﬁ-
ciency, respiratory distress syndrome and cystic ﬁbrosis
[47,46]. On the other hand however, the RBC was reported to
decrease in chronic liver disease, kidney dysfunction, hereditary
anemia(s), free radical pathology, toxic metals and impaired
catabolic process that lead to iron deﬁciency, vitamin B6, B12
deﬁciency and folic acid deﬁciency [41,28]. It was also reported
that HGB is increased in emphysema, severe asthma, and other
forms of long-standing respiratory distress [8]. Clearly mild
asthma acted as hypoxic stimulus to spleen hyper-function,
hence elevated the release and/or production of RBC and their
related indices. On the contrary, in severe persistent asthma, the
relatively longer-standing bronchial obstruction induced hyp-
oxic resulted in the sources RBC pathology. Evidently, the ran-dom distribution of red blood cell (RDW) width indicates the
consistency of the size of the red blood cells. This index can help
to clarify the sources RBC pathology. The average value is
about 13 but it increases because of folic acid deﬁciency anemia,
B12 deﬁciency anemia (pernicious anemia), hemolytic anemia
and transfusion. It decreases due to poor iron absorption, deﬁ-
cient B6, rheumatoid arthritis [8]. In addition, it has been sug-
gested that an elevated hematocrit may be due to spleen hyper-
function, and a reduced hematocrit may indicate low thymus
function. MCV increase or decrease along with an increase or
decrease in MCH is a signiﬁcant ﬁnding for folic acid and/or
B12 need (increase) or iron, copper or vitamin B6 need
(decrease). MCV and MCH should always be viewed together.
Mean Corpuscular Hemoglobin Concentration (MCHC) is the
average hemoglobin concentration per unit volume (100 ml) of
packed red cells indicated by MCHC [39,50]. The average pop-
ulation values range from 32% to 35%. MCHC is increased in
and decreased in the same conditions as the MCV. Two excep-
tions – in spherocytosis, the MCHC is elevated but not in per-
nicious anemia.
The second ﬁndings of the present study were elevated
WBC, NEU, EOS, LYM and BAS in moderate and severe
asthma patients. Clearly, chronic asthma inducted progressive
changes in the total WBC, neutrophil, lymphocyte and eosin-
ophil count. The increase was more profound in group 4,
but was also seen in group 3 to some extent. Perhaps these
changes can be used in evaluating complications of asthma,
such as infections [14,38]. In other words an increase in
332 A.S.A. Haffor et al.eosinophils, basophils, neutrophils and lymphocytes reﬂects a
bronchial infection and/or parenchyma infection secondary
to bronchial inﬂammation that was caused by microorganisms
during high stages of chronic asthma. It is very important to
realize that the white blood cell differential is often used to
help diagnose diseases and conditions that affect one or more
different types of WBCs. The ﬁve types include: neutrophils,
lymphocytes, monocytes, eosinophils and basophils. The
differential totals the number of each type and determines if
the cells are present in normal proportion to one another, if
one cell type is increased or decreased, or if immature cells
are present. This information is useful in helping to diagnose
the speciﬁc progression in causing an illness, such as asthma,
allergies, inﬂammations, and neoplasm. In addition, some dis-
eases trigger a response by the immune system that causes an
increase in certain types of WBCs [15,48]. A differential may
give clues to the speciﬁc cause of that immune e response. Cer-
tainly bronchial hyperresponsiveness (BHR) involves physio-
logical mixed events that include inﬂammation and cellular
inﬁltration leading to airway narrowing and a subsequent
interference with airﬂow [6,1,2,23,24]. There is considerable
interest in the role of the speciﬁc immune response that is asso-
ciated with both the development and regulation of inﬂamma-
tion [17,23,24]. In particular, research has focused on an
imbalance between Th1 and Th2 cytokine proﬁles and evi-
dence that allergic diseases, and possibly asthma, are charac-
terized by a shift toward a Th2 cytokine-like disease, either
as over expression of Th2 or under expression of Th1 [18]. Air-
way inﬂammation in asthma may represent a loss of normal
balance between two ‘‘opposing” populations of the lympho-
cytes. The current ‘‘hygiene hypothesis” of asthma illustrates
how this cytokine imbalance may explain some of the dramatic
increases in asthma prevalence in westernized countries. This
hypothesis is based on the assumption that the immune system
of the newly born is skewed toward Th2 cytokine generation
[17,19,26].
A third ﬁnding of the present study was the development of
broncho-pulmonary-aspergillosis (BPA) that was observed in
severe asthma, group 4. BPA is known to occur in chronic cav-
ities in patients with mild immune compromise and lung dam-
age [34,32]. It has been shown that BPA is a relatively common
association with severe asthma [47,33]. ABPA, occurring
almost exclusively in asthma patients, is characterized radio-
graphically by ﬂeeting pulmonary alveolar opacities caused
by deposition of immune complexes and inﬂammatory cells
within the lung parenchyma. Mucus plugging and bronchial
wall thickening can be expected in time. Aspergilloma, occur-
ring in patients with structural lung disease, typically appears
radiographically as a focal intra-cavitary mass and is
characterized initially by an increase in the wall thickness of
a pre-existing cavity or cyst [14,31,11].
Permanent structural changes can occur in the airway lead-
ing to airway remodeling secondary to bronchial epithelial cell
shedding and activation leading to a progressive loss of lung
function that is not prevented by or fully reversible by current
therapy. Airway remodeling involves an activation of many of
the structural cells, with consequent free radical-inducted per-
manent changes in the airway that increase airﬂow obstruction
and airway responsiveness and render the patient less
responsive to therapy [25,22,7]. These structural changes can
include thickening of the sub-basement membrane, sub
epithelial ﬁbrosis, airway smooth muscle hypertrophy andhyperplasia, blood vessel proliferation and dilation, and
mucous gland hyperplasia and hyper secretion. Regulation of
the repair and remodeling process is not well established, but
both the process of repair and its regulation are likely to be
key events in explaining the persistent nature of the disease
and limitations to a therapeutic response.
Although our study was not designed to explore reasons for
airway morphological changes and/or remodeling, its ﬁndings
provided an objective quantitative rating scoring numerical
measure regarding the clinical indications on CXR of chronic
asthma patients. Bousquet et al., studied 452 asthmatic
patients using high resolution computed tomography and
found increases in ﬁxed abnormality that were dependent on
the severity of asthma and that included bronchial wall thick-
ening, secondary line shadows and emphysema-like images
secondary to a cicatricle peribronchial ﬁbrosis [27,10]. They
emphasized that chronic inﬂammation induced wall thickness
[23,24] involved membranous and cartilaginous airways of
asthmatic patients and the airway smooth muscle shortening
required to occlude the lumen was less in asthmatic than
non-asthmatic airways [16,3,11]. Therefore, the increased wall
thickness was due to increased areas of epithelium, muscle, and
submucosa that could be as crucial as smooth muscle shorten-
ing in determining the airway responsiveness.
Conclusions
Based on the results of the present research it can be
concluded:
(1) The dynamic of red blood cells can be used to differen-
tiate early stages of asthma whereas the dynamic white
blood cells can be used to differentiate late stages of
asthma.
(2) Monitoring CBC parameters can be an objective esti-
mate of the S–K score in order to classify the severity
of asthma CXR without the need for X-ray equipment
setup, hence provides quantitative and objective numer-
ical value for the purpose of asthma patients’ treatment
progression and follow up.
(3) Severe chronic asthma inducts permanent bronchial
remolding and parenchymal structural pathological
alterations that can be objectively rated on CXR.Conﬂict of interest
No conﬂict of interest.
Acknowledgment
This research project was supported by SAU-Deanship for Sci-
entiﬁc Research; Grant No (19=ص=1433).
References
[1] O. Akbari, J.L. Faul, E.G. Hoyte, G.J. Berry, J. Wahlstrom, M.
Kronenberg, R.H. DeKruyff, D.T. Umetsu, CD4+ invariant T-
cell-receptor+ natural killer T cells in bronchial asthma, N.
Engl. J. Med. 354 (2006) 1117–1129.
[2] American Thoracic Society (ATS), What constitutes an adverse
health effect of air pollution? Ofﬁcial statement of the American
Reliable quantitative score for grading chest X-ray 333Thoracic Society, Am. J. Respir. Crit. Care. Med. 161 (2 Pt 1)
(2000) 665–673.
[3] N. Awadh, N. Mu¨ller, C. Park, R. Abboud, J. FitzGerald,
Airway wall thickness in patients with near fatal asthma and
control groups: assessment with high resolution computed
scanning, Thorax 53 (1988) 248–254.
[4] M. Berry, A. Morgan, D.E. Shaw, D. Parker, R. Green, C.
Brightling, P. Bradding, A.J. Wardlaw, I.D. Pavord,
Pathological features and inhaled corticosteroid response of
eosinophilic and non-eosinophilic asthma, Thorax 62 (2007)
1043–1049.
[5] D. Brasﬁeld, G. Hicks, S. Soong, R.E. Tiller, The chest
roentgenogram in cystic ﬁbrosis: a new scoring system,
Pediatrics 63 (1) (1979) 24–29.
[6] C.E. Brightling, P. Bradding, F.A. Symon, S.T. Holgate, A.J.
Wardlaw, I.D. Pavord, Mast-cell inﬁltration of airway smooth
muscle in asthma, N. Engl. J. Med. 346 (2002) 1699–1705.
[7] S. Bin-Jalia, M. Dallak, A.S.A. Haffor, Effect of hyperoxia on
the ultrastructural pathology of alveolar epithelium in relation
to glutathione peroxidase, lactate dehydrogenase activities, and
free radical production in rats, Rattus norvegicus, Ultrastruct.
Pathol. 33 (2009) 1–11, 2009, USA.
[8] J.D. Bessman, P.R. Gilmer, F.H. Gardner, Improved
classiﬁcation of anemias by MCV and RDW, Am. J. Clin.
Pathol. 80 (1983) 322–326.
[9] J.D. Bessman, P.R. Gilmer, F.H. Gardner, Too early to put
down RDW for discriminating iron deﬁciency and thalassemia,
Am. J. Clin. Pathol. 86 (1986) 693–695.
[10] J. Bousquet, P. Chanez, J.Y. Lacoste, G. Barneon, N.
Ghavanian, I. Enander, P. Venge, S. Ahlstedt, J. Simony-
Lafontaine, P. Godard, et al, Eosinophilic inﬂammation in
asthma, N. Engl. J. Med. 323 (1990) 1033–1039.
[11] A.D. Cluroe, R. Beasley, S. Lorimer, L. Holloway, The
relationship between pulmonary interstitial emphysema and
clinical features in fatal asthma, J. Asthma 31 (1994) 65–69.
[12] J. Cornbelt, Spurious results from automated hematology cell
counters, Lab. Med. 14 (1983) 509–514.
[13] S.P. Conway, M.N. Pond, I. Bowler, D.L. Smith, E.J. Simmond,
D.N. Joanes, G. Hambleton, E.J. Hiller, D.E. Stableforth, P.
Weller, J.M. Littlewood, The Chest radiograph in cystic ﬁbrosis:
a new scoring system compared with Chrispin–Norma and
Brasﬁeld scores, Thorax 49 (1994) 860–862.
[14] G. Cox, Glucocorticoid treatment inhibits apoptosis in human
neutrophils, J. Immunol. 154 (1995) 4719–4725.
[15] R. Djukanovic, W.R. Roche, J.W. Wilson, C.R. Beasley, O.P.
Twentyman, R.H. Howarth, S.T. Holgate, Mucosal
inﬂammation in asthma, Am. Rev. Respir. Dis. 142 (1990)
434–457.
[16] M. Dunnill, G. Massarella, J. Anderson, Comparison of the
quantitative anatomy of the bronchi in normal subjects, in status
asthmaticus, in chronic bronchitis, and in emphysema, Thorax
24 (1969) 176–179.
[17] W. Eder, M.J. Ege, E. von Mutius, The asthma epidemic, N.
Engl. J. Med. 355 (21) (2006) 2226–2235, Review.
[18] J.V. Fahy, K.W. Kim, J. Liu, H.A. Boushey, Prominent
neutrophilic inﬂammation in sputum from subjects with
asthma exacerbation, J. Allergy. Clin. Immunol. 95 (1995)
843–852.
[19] J.E. Gern, R.F. Lemanske Jr, W.W. Busse, Early life origins of
asthma, J. Clin. Invest. 104 (7) (1999) 837–843 (Review).
[20] R.H. Green, C.E. Brightling, S. McKenna, B. Hargadon, D.
Parker, P. Bradding, A.J. Wardlaw, I.D. Pavord, Asthma
exacerbations and sputum eosinophil counts: a randomised
controlled trial, Lancet 360 (2002) 1715–1721.
[21] E.L. Gottfried, Erythrocyte indexes with the electronic counter,
N. Engl. J. Med. 300 (1979) 1277.
[22] A.S.A. Haffor, Effects of gram-negative bacteria, E. coli and
cold exposure on free radicals production, lactatedehydrogenase and glutathione peroxidase activity, in rats
lungs, Saudi J. Biol. Sci. 14 (2) (2007) 177–183, KSA.
[23] A.S.A. Haffor, Effect of commiphora molmol on leukocyte
proliferation in relation to histological alterations before and
during healing from injury, Saudi J. Biol. Sci. 17 (2010) 139–146,
KSA.
[24] A.S.A. Haffor, Effect of myrrh commiphora molmol on
leukocyte levels before and during healing from gastric ulcer
or skin injury, J. Immunotoxicol. 7 (1) (2010) 68–75, USA.
[25] S.T. Holgate, R. Polosa, The mechanisms, diagnosis, and
management of severe asthma in adults, Lancet 368 (9537)
(2006) 780–793, Review.
[26] L.J. Horwood, D.M. Fergusson, F.T. Shannon, Social and
familial factors in the development of early childhood asthma,
Pediatrics 75 (5) (1985) 859–868.
[27] C.J. Imperatori, Cicatricial stenosis of the trachea report of
three cases, Arch. Otolaryngol. 1 (6) (1925) 624–628.
[28] C.S. Johnson, C. Tegos, E. Beutler, Thalassemia minor: routine
erythrocyte measurements and differentiation from iron
deﬁciency, Am. J. Clin. Pathol. 80 (1983) 31–36.
[29] S. Kido, J. Ikezoe, H. Naito, et al, Clinical evaluation of
pulmonary nodules with single-exposure dual-energy
subtraction chest radiography with an iterative noise-reduction
algorithm, Radiology 194 (1995) 407–412.
[30] J.E. Kuhlman, J. Collins, G.N. Brooks, D.R. Yandow, L.S.
Broderick, Dual-energy subtraction chest radiography: what to
look for beyond calciﬁed nodules, Radiographics 26 (2006) 79–
92.
[31] C. Lamblin, P. Gosset, I. Tillie-Leblond, F. Saulnier, C.H.
Marquette, B. Wallaert, A.B. Tonnel, Bronchial neutrophilia in
patients with noninfectious status asthmaticus, Am. J. Respir.
Crit. Care. Med. 157 (1998) 394–402.
[32] R. Louis, L.C. Lau, A.O. Bron, A.C. Roldaan, M.
Radermecker, R. Djukanovic, The relationship between
airways inﬂammation and asthma severity, Am. J. Respir.
Crit. Care. Med. 161 (2000) 9–16.
[33] M. Mahdavinia, L.C. Grammer, Management of allergic
bronchopulmonary aspergillosis: a review and update, Ther.
Adv. Respir. Dis. 6 (3) (2012) 173–187.
[34] T.R. Mosmann, H. Cherwinski, M.W. Bond, M.A. Giedlin, R.
L. Coffman, Two types of murine helper T cell clone: I.
Deﬁnition according to proﬁles of lymphokine activities and
secreted proteins, J. Immunol. 136 (1986) 2348–2357.
[35] S. McClure, E. Custer, J.D. Bessman, Improved detection of
early iron deﬁciency anemia in non-anemic subjects, JAMA 253
(1985) 1021–1023.
[36] NAC, National Asthma Campaign, Asthma Management
Hand Book, National Campaign, Canberra, 2002.
[37] NAEPP, National Asthma Education and Prevention Program
Expert Panel Report 3: Guidelines for the Diagnosis and
Management of Asthma – National Institutes of Health (NIH)
– National Heart, Lung, and Blood Institute. NIH Publication.
2013–2014..
[38] C.L. Ordonez, T.E. Shaughnessy, M.A. Matthay, J.V. Fahy,
Increased neutrophil numbers and IL-8 levels in airway
secretions in acute severe asthma: clinical and biologic
signiﬁcance, Am. J. Respir. Crit. Care. Med. 161 (2000) 1185–
1190.
[39] B.A. Payne, R.V. Pierre, M.A. Morris, Use of instruments to
obtain red blood cell proﬁles, J. Med. Tech. 2 (1985) 379–388.
[40] D.S. Robinson, Q. Hamid, S. Ying, A. Tsicopoulos, J. Barkans,
A.M. Bentley, C. Corrigan, S.R. Durham, A.B. Kay,
Predominant Th2-like bronchoalveolar T-lymphocyte
population in atopic asthma,N.Engl. J.Med. 326 (1992) 298–304.
[41] M.S. Rose, Epitaph for the MCHC, Br. J. Med. 4 (1971) 169.
[42] W.J. Williams, Examination of the blood, in: W.J. Williams, E.
Beutler, A.J. Erslev, M.A. Lichtman (Eds.), Hematology, 3d
ed., McGraw-Hill, New York, 1983, pp. 9–14.
334 A.S.A. Haffor et al.[43] C.M. Schaefer-Prokop, M. Prokop, A. Schmidt, U. Neitzel, M.
Galanski, Selenium radiography versus storage phosphor and
conventional radiography in the detection of simulated chest
lesions, Radiology 201 (1996) 45–50.
[44] R.P. Schleimer, A. Kato, R. Kern, D. Kuperman, P.C. Avila,
Epithelium: at the interface of innate and adaptive immune
responses, J. Allergy Clin. Immunol. 120 (2007) 1279–1284.
[45] H. Shwachmann, I.L. Kulczycki, Long-term study of one
hundred ﬁve patients with cystic ﬁbrosis, AMA J. Dis. Child.
96 (1) (1958) 6–15.
[46] P. Vijayanand, G. Seumois, C. Pickard, R.M. Powell, G. Angco,
D. Sammut, S.D. Gadola, P.S. Friedmann, R. Djukanovic,
Invariant natural killer T cells in asthma and chronic obstructive
pulmonary disease, N. Engl. J. Med. 356 (2007) 1410–1422.[47] S.E. Wenzel, L.B. Schwartz, E.L. Langmack, J.L. Halliday, J.B.
Trudeau, R.L. Gibbs, H.W. Chu, Evidence that severe asthma
can be divided pathologically into two inﬂammatory subtypes
with distinct physiologic and clinical characteristics, Am. J.
Respir. Crit. Care. Med. 160 (1999) 1001–1008.
[48] M. Wills-Karp, J. Luyimbazi, X. Xu, B. Schoﬁeld, T.Y. Neben,
C.L. Karp, D.D. Donaldson, Interleukin-13: central mediator of
allergic asthma, Science 282 (1998) 2258–2261.
[49] B.J. Winer, Statistical Principles in Experimental Design, 2nd
ed., McGraw-Hill, N.Y., 1971.
[50] M.M. Wintrobe, Principles of hematologic examination, in: M.
M. Wintrobe (Ed.), Clinical Hematology, 8th ed., Lea &
Febiger, Philadelphia, 1981, pp. 7–19.
